Intracellular Reassociation of RNA-DNA Hybrids that Activates RNAi in HIV-Infected Cells.
Ontology highlight
ABSTRACT: Human immunodeficiency virus Type 1 (HIV-1) is the major cause of acquired immune deficiency syndrome (AIDS). In 2014, it was estimated that 1.2 million people died from AIDS-related illnesses. RNA interference-based therapy to block HIV replication is a field that, as of now, is without any FDA-approved drugs available for clinical use. In this chapter we describe a protocol for testing and utilizing a new approach that relies on reassociation of RNA-DNA hybrids activating RNAi and blocking HIV replication in human cells.
SUBMITTER: Martins AN
PROVIDER: S-EPMC6941940 | biostudies-literature | 2017
REPOSITORIES: biostudies-literature
ACCESS DATA